Zatsopano zimathandizira kupita patsogolo.Zikafika pazatsopano pakupanga mankhwala atsopano ndi mankhwala achire, FDA's Center for Drug Evaluation and Research (CDER) imathandizira makampani opanga mankhwala panjira iliyonse.Ndi kumvetsetsa kwake kwa sayansi yomwe imagwiritsidwa ntchito popanga zinthu zatsopano, kuyesa ndi kupanga njira, ndi matenda ndi mikhalidwe yomwe mankhwala atsopano amapangidwira, CDER imapereka upangiri wasayansi ndi malamulo ofunikira kuti abweretse mankhwala atsopano pamsika.
Kupezeka kwa mankhwala atsopano ndi zinthu zachilengedwe nthawi zambiri kumatanthauza njira zatsopano zothandizira odwala komanso kupita patsogolo kwa chithandizo chamankhwala kwa anthu aku America.Pachifukwa ichi, CDER imathandizira zatsopano ndipo imathandizira kupititsa patsogolo chitukuko chatsopano chamankhwala.
Chaka chilichonse, CDER imavomereza mitundu ingapo yamankhwala atsopano ndi zinthu zachilengedwe:
1. Zina mwazinthuzi ndi zatsopano zomwe sizinagwiritsidwepo ntchito pazachipatala.Pansipa pali mndandanda wazinthu zatsopano zamamolekyu ndi zinthu zatsopano zochizira zamankhwala zovomerezedwa ndi CDER mu 2021. M'ndandandawu mulibe katemera, zinthu zomwe sizingawope, magazi ndi zinthu zamagazi, zotuluka m'madzi a m'magazi, ma cellular ndi ma gene therapy, kapena zinthu zina zovomerezeka mu 2021 ndi Center for Biologics Evaluation and Research.
2. Zina ndizofanana, kapena zokhudzana ndi zinthu zomwe zidavomerezedwa kale, ndipo amapikisana ndi malondawo pamsika.Onani Drugs@FDA kuti mudziwe zambiri zamankhwala ovomerezeka a CDER ndi zinthu zachilengedwe.
Mankhwala ena amasankhidwa kukhala magulu atsopano a mamolekyu ("NMEs") pofuna kuwunikanso ndi FDA.Zambiri mwazinthuzi zimakhala ndi zigawo zogwira ntchito zomwe sizinavomerezedwe ndi FDA kale, kaya ngati mankhwala amodzi kapena ngati gawo la mankhwala osakaniza;mankhwalawa nthawi zambiri amapereka zofunika zatsopano mankhwala kwa odwala.Mankhwala ena amadziwika kuti ndi ma NME pazolinga zoyang'anira, komabe amakhala ndi magawo omwe amagwirizana kwambiri ndi zinthu zomwe zidavomerezedwa kale ndi FDA.Mwachitsanzo, CDER imayika m'magulu azinthu zachilengedwe zomwe zatumizidwa pansi pa ndime 351 (a) ya Public Health Service Act ngati ma NME pofuna kuwunikanso ndi FDA, mosasamala kanthu kuti bungweli lidavomerezapo kale gawo logwirizana ndi chinthu china.Magulu a FDA a mankhwala ngati "NME" kuti awonedwenso ndizosiyana ndi zomwe FDA imatsimikiza ngati mankhwala ndi "mankhwala atsopano" kapena "NCE" mu tanthauzo la Federal Food, Drug, and Cosmetic Act.
Ayi. | Dzina la Mankhwala | Yogwira pophika | Tsiku Lovomerezeka | Kugwiritsa ntchito kovomerezeka ndi FDA pa tsiku lovomerezeka * |
37 | Exkivity | mobocertinib | 9/15/2021 | Kuchiza khansa ya m'mapapo yotsogola kwanuko kapena ya metastatic yomwe si yaing'ono yama cell ndi epidermal growth factor receptor exon 20 insertion masinthidwe |
36 | Skytrofa | lonapegsomatropin-tcgd | 8/25/2021 | Kuchiza zazifupi chifukwa cha kusakwanira katulutsidwe ka endogenous growth hormone |
35 | Korsuva | amafanana | 8/23/2021 | Kuchiza pruritus yokhazikika mpaka yowopsa yokhudzana ndi matenda a impso m'magulu ena |
34 | Welireg | belzutifan | 8/13/2021 | Kuchiza matenda a von Hippel-Lindau pansi pazifukwa zina |
33 | Nexviazyme | avalglucosidase alfa-ngpt | 8/6/2021 | Kuchiza matenda a Pompe mochedwa |
Cholengeza munkhani | ||||
32 | Saphnelo | anifrolumab-fnia | 7/30/2021 | Kuchiza zolimbitsa thupi mpaka zowopsa za systemic lupus erythematousus limodzi ndi chithandizo chokhazikika |
31 | Bylvay | odevixibat | 7/20/2021 | Kuchiza pruritus |
30 | Rezurock | belumosudil | 7/16/2021 | Kuchiza matenda osatha kumezetsa-kuyerekeza ndi omwe akudwala pambuyo pakulephera kwa mizere iwiri yam'mbuyomu yamankhwala |
29 | fexidazole | fexidazole | 7/16/2021 | Kuchiza anthu African trypanosomiasis chifukwa tizilombo Trypanosoma brucei gambinse |
28 | Kerendia | finerenone | 7/9/2021 | Kuchepetsa chiopsezo cha zovuta za impso ndi mtima mu matenda a impso osatha omwe amakhudzana ndi matenda amtundu wa 2 |
27 | Rylaze | asparaginase erwinia chrysanthemi (recombinant) -rywn | 6/30/2021 | Kuchiza pachimake lymphoblastic khansa ya m'magazi ndi lymphoblastic lymphoma odwala amene sagwirizana ndi E. coli-derived asparaginase mankhwala, monga chigawo chimodzi cha mankhwala amphamvu. |
Cholengeza munkhani | ||||
26 | Aduhelm | aducanumab-avwa | 6/7/2021 | Kuchiza matenda a Alzheimer's |
Cholengeza munkhani | ||||
25 | Brexafemme | ibrexafuningerp | 6/1/2021 | Kuchiza vulvovaginal candidiasis |
24 | Lybalvi | olanzapine ndi samidorphan | 28/5/2021 | Kuchiza schizophrenia ndi zina za bipolar I matenda |
23 | Truseltiq | infigratinib | 28/5/2021 | Kuchiza cholangiocarcinoma amene matenda akwaniritsa zofunika zina |
22 | Lumakras | sotorasib | 28/5/2021 | Kuchiza mitundu ya khansa ya m'mapapo yosakhala yaying'ono |
Cholengeza munkhani | ||||
21 | Pylarify | piflufolastat F18 | 26/5/2021 | Kuzindikira zotupa za prostate-specific membrane antigen-positive mu khansa ya prostate |
20 | Rybrevant | amivantamab-vmjw | 5/21/2021 | Kuchiza kagawo kakang'ono ka khansa ya m'mapapo yosakhala yaying'ono |
Cholengeza munkhani | ||||
19 | Mverani | pegcetacoplan | 5/14/2021 | Kuchiza paroxysmal nocturnal hemoglobinuria |
18 | Zynlonta | loncastuximab tesirine-lpyl | 23/4/2021 | Kuchiza mitundu ina ya kubwereranso kapena refractory lalikulu B-cell lymphoma |
17 | Jemperli | dostarlimab-gxly | 22/4/2021 | Kuchiza khansa ya endometrial |
Cholengeza munkhani | ||||
16 | Nextstellis | drospirenone ndi estetrol | 4/15/2021 | Kupewa mimba |
15 | Qelbree | viloxazine | 4/2/2021 | Kuchiza chidwi cha deficit hyperactivity disorder |
14 | Zegalogue | dasiglucagon | 3/22/2021 | Kuchiza kwambiri hypoglycemia |
13 | Ponvory | ponesimod | 3/18/2021 | Kuchiza mitundu yobwereranso ya multiple sclerosis |
12 | Fotivda | tivozanib | 3/10/2021 | Kuchiza renal cell carcinoma |
11 | Azstarys | serdexmethylphenidate ndi | 3/2/2021 | Kuchiza chidwi cha deficit hyperactivity disorder |
dexmethylphenidate | ||||
10 | Pepaxto | melphalan flufenamide | 2/26/2021 | Kuchiza myeloma yobwerera m'mbuyo kapena refractory |
9 | Nulibry | fosdenopterine | 2/26/2021 | Kuchepetsa chiopsezo cha kufa kwa molybdenum cofactor Type A |
Cholengeza munkhani | ||||
8 | Amondi 45 | casimersen | 2/25/2021 | Kuchiza Duchenne muscular dystrophy |
Cholengeza munkhani | ||||
7 | Kosela | trilacicilib | 2/12/2021 | Kuchepetsa chemotherapy-induced myelosuppression mu kansa yaing'ono ya m'mapapo |
Cholengeza munkhani | ||||
6 | Evkeeza | evinacumab-dgnb | 2/11/2021 | Kuchiza homozygous Famer hypercholesterolemia |
5 | Ukoniq | chimbale | 2/5/2021 | Kuchiza marginal zone lymphoma ndi follicular lymphoma |
4 | Tepmetko | tepotinib | 2/3/2021 | Kuchiza khansa ya m'mapapo yosakhala yaying'ono |
3 | Lupkynis | voclosporin | 1/22/2021 | Kuchiza lupus nephritis |
Mayesero a Mankhwala Chithunzithunzi | ||||
2 | Cabenuva | cabotegravir ndi rilpivirine (zophatikizidwa) | 1/21/2021 | Kuchiza HIV |
Cholengeza munkhani | ||||
Mayesero a Mankhwala Chithunzithunzi | ||||
1 | Verquvo | vericiguat | 1/19/2021 | Kuchepetsa chiopsezo cha kufa kwa mtima ndi kugonekedwa m'chipatala chifukwa cha kulephera kwa mtima kosatha |
Mayesero a Mankhwala Chithunzithunzi |
Zomwe zalembedwa "zovomerezeka ndi FDA" patsamba lino ndizongowonetsera zokha.Kuti muwone zovomerezeka ndi FDA zogwiritsira ntchito [mwachitsanzo, zizindikiro, anthu, chiwerengero cha anthu), ndondomeko ya mlingo pa chilichonse mwazinthuzi, onani Chidziwitso Chaposachedwa Chovomerezedwa ndi FDA.
Tchulani kuchokera patsamba la FDA:https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021
Nthawi yotumiza: Sep-27-2021